4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001470831-26-001003
Chief Financial Officer sold 45,173 shares at $2.71 ($122,487)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Adams Kendra Chief Financial Officer | 2026-11-12 | Sale 10b5-1 | −45,173 | $2.71 | $122,487 | 337,150 | D |
| Open-market sales · 45,173 sh · avg $2.71 · $122,487 | |||||||
Loading xslF345X06/wk-form4_1794604206.xml…